-
152022.11
[Main Questions 6] Answers to questions during the 2022 extraordinary ..
We would like to express our sincere gratitude to our shareholders for their interest in the 2022 extraordinary general ..
-
152022.11
[IR] Review of Non-Deal Roadshow held by institutional investors on Ju..
SCM Lifescience Inc. held a Non-Deal Road Show (NDR) for a total of 4 domestic institutional investors on July 25-26 to ..
-
152022.11
SCM Lifescience, systemic sclerosis research paper published in ‘Inte..
SCM Lifescience Inc.’s Research & Business Innovative Development Division Managing Director Seok-jo Kim published a..
-
152022.11
[IR] Review of the Non-Deal Road Show held from June 7th to 8
SCM Lifescience, Inc. held its first Non-Deal Road Show (NDR) on June 7-8 to explain the essential value of the company ..
-
152022.11
[IR] Non-Deal Roadshow for institutional investors will be held from J..
SCM Lifescience, Inc. will hold a Non-Deal Road Show (NDR) for domestic institutional investors from June 7-8 to enhance..
-
152022.11
[Open Innovation] Participated in BIO KOREA 2022 Business Forum ‘Bio L..
SCM Lifescience, Inc. was selected as a business forum at Bio Korea 2022,which will be Korea's representative bio-health..
-
152022.11
[Open Innovation] Participation in the 2022 Korean Tissue Engineering..
On April 29, the R&D department under the Research & Business Innovative Development Division of SCM Lifescience..
-
152022.11
[Open Innovation] The Korean Ophthalmological Society holds R&D Open I..
As promised at the 8th regular general meeting of shareholders,we would like to inform you of the results of the R&D..
-
152022.11
Guide to SCM Lifescience Official YouTube Channel
Dear Shareholders,Due to the environment where information from unknown sources is easily shared,unreliable information ..